🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 81 of 200 · A–Z by INN

  1. freeze-dried polyethylene glycol-treated human normal immunoglobulin

    KENKETU GLOVENIN-I PARTIAL CHANGE APPROVAL

    PMDA: approved

  2. freeze-dried smallpox vaccine prepared in cell culture

    FREEZE-DRIED SMALLPOX VACCINE PREPARED IN CELL CULTURE LC16 “KMB” PARTIAL CHANGE APPROVAL

    PMDA: approved

  3. fremanezumab

    AJOVY Lacuna Pharma Pty Ltd

    EMA: approved · TGA: approved

    N02CD03

  4. fremanezumab-vfrm

    AJOVY Teva Pharma GmbH

    INJECTION FDA: approved

  5. frovatriptan succinate

    FROVATRIPTAN SUCCINATE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  6. fruquintinib

    FRUZAQLA Takeda

    ORAL FDA: approved · EMA: approved · NMPA: clinical trials

    L01EK

  7. ftl001

    NMPA: clinical trials

  8. fulvestrant

    FULVESTRANT ACCORD Lacuna Pharma Pty Ltd

    INTRAMUSCULAR FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L02BA03

  9. furazolidone

    FUROXONE

    ORAL FDA: approved

  10. furmonertinib

    NMPA: clinical trials

  11. furosemide

    APO-FRUSEMIDE Alphapharm Pty Ltd

    INJECTION FDA: approved · EMA: unknown · TGA: approved

    C03CA01

  12. fusidate

    FUCIDIN Lacuna Pharma Pty Ltd

    TGA: approved

  13. futibatinib

    LYTGOBI

    ORAL FDA: approved · EMA: approved · PMDA: approved

    L01EN04

  14. fwd1802

    NMPA: clinical trials

  15. g-csf

    NMPA: clinical trials

  16. gabapentin

    APX-GABAPENTIN Viatris Pharmaceuticals Co.,

    ORAL FDA: approved · TGA: approved

  17. gabapentin enacarbil

    HORIZANT

    ORAL FDA: approved

  18. gabapentin encarbil

    GABAPENTIN ENCARBIL

    ORAL FDA: approved

  19. gadobenate dimeglumine

    MULTIHANCE

    INTRAVENOUS FDA: approved

  20. gadobutrol

    GADAVIST

    INTRAVENOUS FDA: approved · NMPA: clinical trials

  21. gadodiamide

    OMNISCAN

    INJECTION FDA: approved

  22. gadofosveset trisodium

    ABLAVAR (PREVIOUSLY VASOVIST)

    INTRAVENOUS FDA: approved · EMA: withdrawn

    V08CA

  23. gadopentetate dimeglumine

    MAGNEVIST

    INJECTION FDA: approved

  24. gadopiclenol

    ELUCIREM

    INTRAVENOUS FDA: approved · EMA: approved

    V08CA12

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources